This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.
2023-03-31-accounts
| COi\TEi\TS |
Page |
| LegalandAdministration |
|
| Chairman'sSummary |
2 |
| Trustees'Report |
3-11 |
| IndependentAuditors'Report |
12-14 |
| StatementofFinancialActivities |
15 |
| Balance Sheet |
16 |
| StatementofCashFlows |
17 |
| NotestotheFinancialStatements |
18-26 |
mmunot
U
ChangingLivesThrough
-
**LEGAL AND ADMINISTRATION ** |
rapy
Research |
| **TRUSTEES ** |
HenryRichardGeersCotterellBtOBE(Chairman) |
|
ReshmaAshrafMason |
|
GuyEdmundSangster |
|
JemmaFreeman |
|
AlexanderJohns |
|
SaffronGuy |
| **COMPANY SECRETARY ** |
ReshmaAshrafMason |
| **REGISTERED OFFICE ** |
BrydenJohnsonLimited |
|
I-4KingsParade |
|
LowerCoombeStreet |
|
Croydon |
|
CRO\AA |
| **DIRECTOR ** |
MarieDimond |
|
Unit15 |
|
AbbevilleMews |
|
88ClaphamParkRoad |
|
London |
|
SW47BX |
| **SECRET ARY TO TRUSTEES ** |
AbigailParry-Williams |
| **FINANCIAL ADVISOR ** |
DavidMcCormick |
| **AUDITORS ** |
BrydenJohnsonLimited |
|
l-4KingsParade |
|
LowerCoombeStreet |
|
Croydon |
|
CRO!AA |
| **SOLICJTORS ** |
Ashurst |
|
BroadwalkHouse |
|
5AppoldStreet |
|
LondonEC2A 2HA |
| **PRl!\CIPAL BAl'\'KERS ** |
BarclaysBankpie |
|
Kensington andChelsea |
|
POBox4599 |
|
LondonSW31XE |
| **INVEST.VIENT MANAGERS ** |
CazenaveCapitalManagement |
|
12Moorgate |
|
London |
|
EC2R6OA |
| GOVERNING DOCUMENT |
TheMemorandumandArticlesofAssociationincorporated26 November |
|
1999 asamendedbyspecialresolution dated30March:2000 |
|
I |
**2023 ** |
**2022 ** |
| **Total Income ** |
|
**£620,770 ** |
**£566,386 ** |
| Net (Deficit)/Gains including Investment Gains |
|
£35,834 |
£(177, I88) |
| **Net Assets ** |
|
**£1,432,748 ** |
**£1,396,914 ** |
| **Unrestricted Funds ** |
|
£1,08I**,249 ** |
**£1,139,681 ** |
|
|
**Un restricted ** |
**Restricted ** |
**Total ** |
**Total ** |
|
|
**Funds ** |
**Funds ** |
**Funds ** |
**Funds ** |
|
|
2023 |
2023 |
2023 |
**2022 ** |
|
**Notes ** |
£ |
£ |
£ |
£ |
| **INCOME FROM: ** |
|
|
|
|
|
| **Donations and legacies ** |
|
8-1,420 |
516,659 |
601.079 |
565,866 |
| **Charitable activities ** |
|
|
|
|
|
| Symposium |
|
|
|
|
|
| Investmentincome |
|
19,691 |
|
19.691 |
520 |
| **Total income ** |
|
104.111 |
516,659 |
620.770 |
566.386 |
| **EXPENDITURE 0:--1: ** |
|
|
|
|
|
| Raising funds |
|
81,394 |
|
81.394 |
64.118 |
| Charitableactivities |
|
81,149 |
422,393 |
503.542 |
679.456 |
| **Total expenditure ** |
2 |
162,543 |
422,393 |
584,936 |
743.574 |
| et income/ (expenditure) beforeinvestment |
|
|
|
|
|
| **(losses) ** |
|
(58,432) |
94.266 |
35,834 |
(I77,188) |
| Netgain/(losses)oninvestments |
7 |
|
|
|
|
| **Net movementin funds ** |
|
(58.432) |
94.266 |
35,834 |
(177,188) |
| Balance broughtforward I**April 2022 ** |
|
1.139,681 |
257.233 |
1.396.91-1 |
1.57-1.102 |
| **Balance carried forward 31 March 2023 ** |
11 |
1,081,249 |
351,499 |
1.432. 748 |
1.396.91-1 |
|
|
**2023 ** |
|
**2022 ** |
|
|
Note |
£ |
£ |
£ |
£ |
| FIXED ASSETS |
|
|
|
|
|
| Tangibleassets |
6 |
|
304 |
|
180 |
| Investments |
7 |
|
_l,060,520 _ |
|
1,192,739 |
|
|
|
1,060,824 |
|
1,192,919 |
| **CURRENT ASSETS ** |
|
|
|
|
|
| Debtors |
8 |
423,403 |
|
37,068 |
|
| Cashatbankandinhand |
|
22,429 |
|
453,773 |
|
|
|
445,832 |
|
490,841 |
|
| **CREDITORS: Amountsfalling ** |
|
|
|
|
|
| **due withinone year ** |
9 |
(73,908) |
|
(286,846) |
|
|
|
|
371,924 |
|
203,995 |
| **NET ASSETS ** |
|
|
1,432,748 |
|
1,396,914 |
| Funds: |
|
|
|
|
|
| Unrestricted |
10 |
|
1,081,249 |
|
1,139,681 |
| Restricted |
11 |
|
351,499 |
|
257,233 |
|
|
|
1,432,748 |
|
1,396,914 |
|
**2023 ** |
**2022 ** |
|
£ |
£ |
| **Cash from operating activities ** |
|
|
| Netcash(usedin)/by operatingactivities |
(--i3l,005) |
377.859 |
| **Cashflows from investing activities ** |
|
|
| Purchaseoffixedassets |
(340) |
|
| Cashwithdrawals (investments) |
(150,000) |
|
| Purchaseofinvestments |
|
|
| Investmentincomereceived |
17,781 |
520 |
|
(132,599) |
520 |
| **Change incash and cash equivalents in the year ** |
**(563,564) ** |
**378,379 ** |
| Cashandcash equivalents atthebeginning oftheyear |
2.458.473 |
1.268.133 |
| **Cash and cash equivalents at the end of the year ** |
**1,894,909 ** |
1,646,512 |
|
|
====== |
|
**2023 ** |
**2022 ** |
| **Net income/(expenditure) for the reporting period ** |
£ |
£ |
| (as per the statement of activities) |
35.834 |
(177.188) |
| Depreciationcharges |
219 |
43,133 |
| Cashwithdrawals(investments) |
150,000 |
|
| Dividends,interestandrent frominvestments |
(17,781) |
(520) |
| Increase/fDecrease)increditors |
(212,939) |
408,145 |
| (Increase)/Decreaseindebtors |
(386,338) |
104.145 |
|
**(431,005) ** |
**377,859 ** |
| **Analysisof change in net funds ** |
|
|
|
2023 |
**2022 ** |
|
£ |
£ |
| Cashat bank |
22,429 |
453,773 |
| Investmentsheldascash |
1,060,520 |
1,192.739 |
| **Total cash and cash equivalents ** |
1,082,949 |
**1,646,512 ** |
| **2. ** |
**EXPENDITURE ** |
2023 |
2022 |
|
|
£ |
£ |
| (a) |
Raising funds(allunrestricted) |
|
|
|
Fundraisingsalariesincludingnational insurance |
94,231 |
81,422 |
|
Travel.subsistence andrelated expenses |
186 |
123 |
|
Events.committeemeetingsetc. |
1,225 |
731 |
|
Marketingandpublicrelations |
5,752 |
1,842 |
|
PersonnelcostsallocatedtoCharitable&Support |
(20,000) |
(20,000) |
|
lnvestrnentcharges |
|
|
|
|
81,394 |
64,118 |
| (b) |
**Charitable activities: ** |
|
|
|
ContributiontoresearchfacilityatStGeorge'sUniversityofLondon |
|
|
|
-Staffincludingrecruitment(restricted) |
350.410 |
-152.1-Q |
|
-Consumables(restricted) |
59,675 |
84,703 |
|
Symposium |
|
|
|
Personnelcostsallocatedtocharitableexpenditure(restricted) |
10,000 |
10,000 |
|
Conference,travelandsubsistence(restricted) |
2,308 |
7,707 |
|
Equipment maintenance |
12,388 |
11,948 |
|
Equipmentdepreciation |
|
42,521 |
|
|
434,781 |
609,021 |
| **(c) ** |
Support (allunrestricted) |
|
|
|
Rent,rates.and utilities |
22.239 |
19,938 |
|
Telephone,printing,postageandstationery |
13.384 |
14.405 |
|
Insurance |
3.543 |
2,979 |
|
Bank andinvestmentcharges |
2.408 |
2,467 |
|
Professionalfees |
|
3,619 |
|
Depreciation |
219 |
612 |
|
Personnelcostsallocatedto administration |
10,000 |
10,000 |
|
Governance-Otherprofessionalcosts |
3,200 |
5,050 |
|
Governance-Accountancyandaudit |
13,768 |
11,365 |
|
|
68.761 |
70,435 |
|
Total |
584,936 |
743,574 |
| **3. ** |
**ST AH COSTS ** |
2023 |
**2022 ** |
|
|
£ |
£ |
|
Wages andsalaries |
82,928 |
75,130 |
|
SocialSecurityCosts |
4.597 |
3,927 |
|
Pensioncontributions |
6.588 |
2,254 |
|
|
94,113 |
81,311 |
| **4. ** |
**:\ET MOVEMENT IN FUNDS ** |
2023 |
**2022 ** |
|
|
£ |
£ |
|
Thisis statedaftercharging: |
|
|
|
Depreciation |
219 |
43.135 |
|
Auditors·remuneration |
8.400 |
8.400 |
| **5. ** |
TRUSTEES' REMUNERATION AND REIMBURSED EXPENSES |
TRUSTEES' REMUNERATION AND REIMBURSED EXPENSES |
TRUSTEES' REMUNERATION AND REIMBURSED EXPENSES |
|
|
|
None ofthe Trusteesreceivedanyremuneration.reimbursed expensestotalled £Nil(2022:£Nil) |
|
|
duringtheyear. |
|
|
TheTrustees are coveredunderaTrusteesliabilitypolicy.Thechargewithintheseaccountsis£3.500 |
|
|
|
(2022: |
|
£2,979)inrespect ofthispolicy. |
|
|
|
|
| 6. |
**TA. GIBLE FIXED ASSETS ** |
Office furniture |
**Clinical ** |
|
|
|
|
**and equipment ** |
**equipment ** |
**Total ** |
|
|
|
£ |
£ |
£ |
|
|
**Cost ** |
|
|
|
|
|
AtIApril2022 |
6,437 |
275,327 |
281,764 |
|
|
Additionsinyear |
340 |
|
|
340 |
|
Disposalsin year |
|
|
|
|
|
Asat31March 2023 |
6,777 |
275,327 |
282,I0-+ |
|
|
**Depreciation ** |
|
|
|
|
|
AtIApril2022 |
6,254 |
275.327 |
281,581 |
|
|
Charge forthe year |
219 |
|
|
219 |
|
Eliminated ondisposal |
|
|
|
|
|
At31March 2023 |
6.473 |
275,327 |
281.800 |
|
|
**Net Book Value ** |
|
|
|
|
|
At3IMarch 2023 |
304 |
|
|
304 |
|
At31March2022 |
183 |
|
|
183 |
| 7. |
**INVESTME~TS ** |
|
**2023 ** |
**2022 ** |
|
|
|
|
£ |
£ |
|
|
MarketvalueatIApril2022 |
|
1,192.739 |
l.l93.498 |
|
|
Additions |
|
|
|
|
|
Disposals |
|
|
|
|
|
Cashwithdrawals |
|
(150,000) |
|
|
|
Realisedlossonsale |
|
|
|
|
|
Unrealised(loss)/profitoninvestments |
|
17,781 |
|
(759) |
|
Marketvalueat31March2023 |
|
1,060.520 |
l.l92.739 |
|
| 8. |
**DEBTORS ** |
2023 |
2022 |
|
|
£ |
£ |
|
Prepaymentsandaccruedincome |
17,394 |
28,919 |
|
Other debtors |
406,009 |
8.149 |
|
|
423,403 |
37.068 |
| **9. ** |
**CREDITORS: AMOUNTS FALLING ** |
2023 |
2022 |
|
**DUE IN LESS THAN O1\EYEAR ** |
£ |
£ |
|
Accrualsanddeferredincome |
66.108 |
282.540 |
|
Othercreditors |
7,800 |
4.306 |
|
|
73,908 |
286,846 |
| **10. ** |
**UNRESTRICTED FUNDS ** |
2023 |
2022 |
|
|
£ |
£ |
|
**General ** |
|
|
|
AtIApril2022 |
1,139,681 |
1,351.918 |
|
(Deficit)forthefinancialyear |
(58.432) |
(212,237) |
|
Al3IMarch 2023 |
1,081,249 |
1.139.681 |
|
Totalfunds |
Total |
Total |
Totalfunds |
|
brought |
incoming |
resources |
carried |
|
forwardas |
resources |
expended |
forward as at |
|
atIApril |
|
|
31March |
|
2022 |
|
|
2023 |
|
£ |
£ |
£ |
£ |
| ProstateCancerResearch |
212,724 |
1,500 |
(36.10I) |
178,123 |
| SGULOvarian |
44,509 |
|
(23.559) |
20,950 |
| ImperialOvarian |
|
7.069 |
|
7,069 |
| AlbertoClinical |
|
50,000 |
|
50,000 |
| HelenFeatherTrials |
|
13,655 |
|
13,665 |
| Generalresearch |
|
400.000 |
(341.775) |
58,225 |
| Wai'sResearchLON |
|
125 |
(125) |
|
| Pete'sCheckpointBlockade |
|
-14.300 |
(20,833) |
23,-167 |
| Totalrestrictedfunds |
257,233 |
516,659 |
(422,393) |
351,499 |
| Unrestrictedfunds |
1,139,681 |
|
(162,543) |
1,081,249 |
| Totalfunds |
1,396,914 |
620,770 |
(584,936) |
1,432,748 |
|
Totalfunds |
Total |
Total |
Totalfunds |
|
brought |
incoming |
resources |
carried |
|
forwardas |
resources |
expended |
forwardasat |
|
atIApril |
|
|
31March |
|
2021 |
|
|
2022 |
|
£ |
£ |
£ |
£ |
| ProstateCancerResearch |
176.432 |
55,350 |
(I9.058) |
212,724 |
| Ovarian |
4-1.509 |
|
|
44,509 |
| Pancreatic |
|
15,606 |
l15.606) |
|
| SeniorLecturerAssociate |
1,2-+3 |
1,000 |
(2.243) |
|
| Generalresearch |
|
401,300 |
(401,300) |
|
| Symposium |
|
|
|
|
| Totalrestrictedfunds |
222.184 |
460,938 |
(438,207) |
257,233 |
| Unrestrictedfunds |
1,351,918 |
224,094 |
(305.367) |
1,139.681 |
| Totalfunds |
1,574,102 |
685,032 |
(743,574) |
1,396,914 |
| **l2. ** |
**A~AL YSIS OF NET ASSETS ** |
**Unrestricted ** |
**Restricted ** |
**Total ** |
|
**BETWEENFUNDS ** |
**Funds ** |
**Funds ** |
|
|
|
£ |
£ |
£ |
|
**Fund balances at 31 March 2023 are represented by: ** |
|
|
|
|
Tangibleassets |
304 |
|
304 |
|
Investments |
1,060,520 |
|
1,060.520 |
|
Netcurrentassets |
20,425 |
351,499 |
371.924 |
|
|
1,081,249 |
351,499 |
1,432.748 |
|
**Fund balancesat 31 March 2022 arerepresented by: ** |
|
|
|
|
Tangibleassets |
180 |
|
180 |
|
Investments |
1,192,739 |
|
1,192,739 |
|
Netcurrentliabilities |
(53,238) |
257,233 |
203,995 |
|
|
I,139,681 |
257,233 |
1,396,914 |
|
|
**Unrestricted ** |
**Restricted ** |
**Total ** |
|
|
**Funds ** |
**Funds ** |
Funds |
|
|
**2022 ** |
**2022 ** |
**2022 ** |
|
**Notes ** |
£ |
£ |
£ |
| **I:\'COME FROM: ** |
|
|
|
|
| **Donationsand legacies ** |
|
92,610 |
4 73.256 |
565,866 |
| **Charitableactivities ** |
|
|
|
|
| Symposium |
|
|
|
|
| **Investment income ** |
|
520 |
|
520 |
| **Total income ** |
|
93,l30 |
473.256 |
566,386 |
| **EXPENDITURE ON: ** |
|
|
|
|
| Raisingfunds |
|
64,l18 |
|
64,118 |
| Charitableactivities |
|
2-+1.2-+9 |
438,207 |
679,456 |
| **Total expenditure ** |
2 |
305,367 |
438.207 |
743,574 |
| **Xet income/(expenditure) before investment ** |
|
|
|
|
| **(losses) ** |
|
(212.237) |
35,049 |
(177.188) |
| et(losses) oninvestments |
7 |
|
|
|
| **:\et movementinfunds ** |
|
(212,237) |
35,049 |
(177,188) |
| Balance brought forward I**April2021 ** |
|
1,351.918 |
222,184 |
1,574,102 |
| **Balance carried forward 31 March 2022 ** |
IO.II |
1,139,681 |
257,233 |
1,396,914 |